Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $1.01 in the prior trading day, iBio Inc (NASDAQ: IBIO) closed at $0.98, down -3.38%. In other words, the price has decreased by -$3.38 from its previous closing price. On the day, 4.98 million shares were traded.
Ratios:
Our goal is to gain a better understanding of IBIO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on May 28, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On November 29, 2021, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $1.50.
On January 22, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on January 22, 2021, with a $3 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 10 ’25 when Duran Felipe bought 9,191 shares for $2.72 per share. The transaction valued at 25,000 led to the insider holds 11,139 shares of the business.
Brenner Martin bought 9,191 shares of IBIO for $25,000 on Jan 10 ’25. The insider now owns 18,316 shares after completing the transaction at $2.72 per share. On Jan 10 ’25, another insider, Banjak Marc, who serves as the Chief Legal Officer of the company, bought 9,191 shares for $2.72 each. As a result, the insider paid 25,000 and bolstered with 11,066 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 42.42 while its Price-to-Book (P/B) ratio in mrq is 0.86.
Stock Price History:
Over the past 52 weeks, IBIO has reached a high of $6.89, while it has fallen to a 52-week low of $0.64. The 50-Day Moving Average of the stock is -70.27%, while the 200-Day Moving Average is calculated to be -63.52%.
Shares Statistics:
A total of 10.07M shares are outstanding, with a floating share count of 9.31M. Insiders hold about 5.67% of the company’s shares, while institutions hold 27.62% stake in the company.
